Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
出版年份 2011 全文链接
标题
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
作者
关键词
-
出版物
Cell Death & Disease
Volume 2, Issue 12, Pages e243-e243
出版商
Springer Nature
发表日期
2011-12-15
DOI
10.1038/cddis.2011.129
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Anticancer Effects of the Nitric Oxide-Modified Saquinavir Derivative Saquinavir-NO against Multidrug-Resistant Cancer Cells
- (2015) Florian Rothweiler et al. NEOPLASIA
- Selective Enrichment of Hepatocellular Cancer Stem Cells by Chemotherapy
- (2013) S Tan et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
- (2011) Jane M Valentine et al. BMC CANCER
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional Analysis of the p53 Pathway in Neuroblastoma Cells Using the Small-Molecule MDM2 Antagonist Nutlin-3
- (2011) T. Van Maerken et al. MOLECULAR CANCER THERAPEUTICS
- Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3
- (2011) M H Aziz et al. ONCOGENE
- Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1
- (2010) Ramesh M. Ray et al. APOPTOSIS
- High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
- (2010) J. Carr-Wilkinson et al. CLINICAL CANCER RESEARCH
- Reactivation of p53: from peptides to small molecules
- (2010) Christopher J. Brown et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- DNA damage response to the Mdm2 inhibitor Nutlin-3
- (2009) Rajeev Verma et al. BIOCHEMICAL PHARMACOLOGY
- Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines
- (2009) Martin Michaelis et al. BIOCHEMICAL PHARMACOLOGY
- MI-63: A novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53
- (2009) J A Canner et al. BRITISH JOURNAL OF CANCER
- Reversal of P-glycoprotein-Mediated Multidrug Resistance by the Murine Double Minute 2 Antagonist Nutlin-3
- (2009) M. Michaelis et al. CANCER RESEARCH
- Restoration of p53 Pathway by Nutlin-3 Induces Cell Cycle Arrest and Apoptosis in Human Rhabdomyosarcoma Cells
- (2009) M. Miyachi et al. CLINICAL CANCER RESEARCH
- Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology
- (2009) L. M. Ellis et al. CLINICAL CANCER RESEARCH
- Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
- (2009) Tom Van Maerken et al. JNCI-Journal of the National Cancer Institute
- Transient Nutlin-3a Treatment Promotes Endoreduplication and the Generation of Therapy-Resistant Tetraploid Cells
- (2008) H. Shen et al. CANCER RESEARCH
- A Multicolor Panel of Novel Lentiviral “Gene Ontology” (LeGO) Vectors for Functional Gene Analysis
- (2008) Kristoffer Weber et al. MOLECULAR THERAPY
- The role of p53 in pigmentation, tanning and melanoma
- (2008) Neil F. Box et al. Pigment Cell & Melanoma Research
- Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties
- (2008) Vera Levina et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search